Consider the risks before prescribing cough syrups containing codeineBack to Messenger
Read time: 1 minute
Since July 2020, cough syrups containing codeine have been on Alberta’s Tracked Prescription Program (TPP Alberta) Type 1 medication list, meaning a prescriber must be registered with TPP Alberta and use a secure TPP pad when prescribing them. This was done after the Alberta College of Pharmacy (ACP) noticed a concerning increase in the number of forgeries reported for these medications—most often Cotridin.
Unfortunately, while prescription forgeries for these medications have dropped in the last two years, the number of pharmacy robberies has increased, with the primary target being Cotridin.
Prescribers are encouraged to consider the clinical risks and societal impact these kinds of medications have. To find out more, please review this joint article from TPP Alberta and ACP.
Questions about TPP-monitored medications? Email TPP.Info@cpsa.ab.ca.
Related NewsAll News & Events
November 16, 2022
Registered with TPP Alberta and need a secure prescription pad? Place your order by Dec. 11
November 10, 2022
Claim CME credits and start a PPIP activity by reviewing your latest MD Snapshot-Prescribing
November 2, 2022
Legislative changes impacting Opioid Use Disorder (OUD) treatment
October 14, 2022
Comments for this post are now closed. If you would like to share your feedback on this topic, please email firstname.lastname@example.org.